LakePharma provides several options for upstream process development of an existing cell line: clone selection via single cell cloning, proof of monoclonality via use of a cell imager, cell line media adaptation, optimization of existing protocols, media and feed screening, bioreactor screening via ambr15. Upon completion of process development projects, LakePharma also offers scale up of the cell line via WAVE or SUB production runs as confirmation.
Please contact email@example.com for more information.
Service offerings include:
• Clones selection
• Cell line adaptation
• Development of a complete scalable production processes
• Optimization of existing processes
• Cell line evaluation
• Medium screening
• Feed screening and feeding strategies
• Pilot scale production
Varies bassed on selected project.
Deliverables (varies based on project scope):
1. Cell lines
2. Technical report covers entire process, from vial thawing to production